Genetron Holdings Ltd (GTH)

Stock Card

$4.02

$0.00 (0.00%)

As on 28-Mar-2024 18:19EDT

Market cap

$127 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

P/B Ratio

1.7

Div. Yield

0 %

Genetron Holdings (GTH) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: -- High: --

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-- Mln
ROE

-0.9 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-0.2
Debt to Equity

0.3
Book Value

$--
EPS

$--
Face value

--
Shares outstanding

31,624,400

6 Years Aggregate

CFO

CN¥-1,813.13 Mln

EBITDA

CN¥-5,525.79 Mln

Net Profit

CN¥-2,727.52 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Genetron Holdings (GTH)	9.2	2.6	9.2	34.0	-58.1	--	--
BSE Sensex^*	-10.1	-3.6	2.5	-5.7	4.9	5.5	10.1
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Mar-2024 | *As on 07-Sep-2026 | #As on 26-Oct-2023

Company	2023	2022	2021
Genetron Holdings (GTH)	9.5	-81.6	-56.4
S&P Small-Cap 600	13.9	-17.4	25.3
BSE Sensex	18.7	4.4	22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Genetron Holdings (GTH)

Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early... screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China. Read more

Co-Founder, CEO & Chairman

Mr. Sizhen Wang
Co-Founder, CEO & Chairman

Mr. Sizhen Wang
Headquarters

Beijing
Website

https://www.genetronhealth.com

FAQs for Genetron Holdings (GTH)

What is the current share price of Genetron Holdings Ltd (GTH) Today?

The share price of Genetron Holdings Ltd (GTH) is $4.02 (NASDAQ) as of 28-Mar-2024 18:19 EDT. Genetron Holdings Ltd (GTH) has given a return of -58.13% in the last 3 years.

What is the current PB & PE ratio of Genetron Holdings Ltd (GTH)?

Since, TTM earnings of Genetron Holdings Ltd (GTH) is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2022	--	--
2021	-0.43	0.16
2020	-1.41	0.17
2019	--	--
2018	--	--

What is the 52 Week High and Low of Genetron Holdings Ltd (GTH)?

The 52-week high and low of Genetron Holdings Ltd (GTH) are Rs -- and Rs -- as of 07-Sep-2026.

What is the market cap of Genetron Holdings Ltd (GTH)?

Genetron Holdings Ltd (GTH) has a market capitalisation of $ 127 Mln as on 10-Apr-2024. As per SEBI classification, it is a Small Cap company.

Should I invest in Genetron Holdings Ltd (GTH)?

Before investing in Genetron Holdings Ltd (GTH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.